X-COR Therapeutics

Name: Upstatement
Price range: $

Creating the first commercially-available extracorporeal CO2 removal device that uses ultra-low-blood flow to treat patients with hypercarbic respiratory failure.

2018 President’s Innovation Challenge Finalist

About X-COR Therapeutics

School

Harvard Medical School, Harvard Business School

Lab

Student i-lab

Connect

Website

Stay In The Know

Learn more about what we have to offer.

Check Eligibility
Subscribe to the i-lab Newsletter
Meet with an Advisor
Visit Our Space

Awards & Affiliations

More Student i-lab Ventures

NeuroModis Therapeutics

STCK Design

Pathway

Exeter22

Stay In The Know